Free Trial

Adaptive Biotechnologies (ADPT) SEC Filings & 10K Form

Adaptive Biotechnologies logo
$8.27 -0.06 (-0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$8.28 +0.01 (+0.06%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Adaptive Biotechnologies SEC Filings

DateFilerForm TypeView
02/19/2025
3:51 PM
Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
7:21 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:11 PM
Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
1:20 PM
Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:13 AM
Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
3:00 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
11/19/2024
5:45 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM
Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/13/2024
8:00 AM
Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/12/2024
12:30 PM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
2:15 PM
Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/07/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
5:07 AM
Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
11/04/2024
9:58 AM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/11/2024
3:14 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
10/10/2024
4:47 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:27 PM
Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:18 PM
Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:15 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:22 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
05/24/2024
11:01 AM
Adaptive Biotechnologies (Filer)
Form DEFA14A
05/17/2024
5:35 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
4:29 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:55 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:46 PM
Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:38 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/06/2024
6:39 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:40 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:40 PM
Adaptive Biotechnologies (Issuer)
PETERSON TYCHO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:41 PM
Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:41 PM
Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:42 PM
Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:43 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:43 PM
Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

03/06/2024
6:45 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADPT) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners